Counterpoint Mutual Funds’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$254K Sell
1,945
-43,514
-96% -$6.51M 0.02% 280
2026
Q2
$6.92M Buy
+45,459
New +$7.57M 0.68% 49
2026
Q1
– Sell
-1,035
Closed -$294K – 451
2025
Q4
$294K Buy
+1,035
New +$324K 0.02% 271
2025
Q1
– Sell
-1,139
Closed -$297K – 383
2024
Q4
$297K Buy
+1,139
New +$287K 0.04% 238
2023
Q4
– Sell
-829
Closed -$132K – 242
2023
Q3
$132K Buy
+829
New +$186K 0.11% 109

Other funds holding PODD

Counterpoint Mutual Funds's PODD Position: Q3 2026 in Review

Counterpoint Mutual Funds reduced its Insulet (PODD) stake by 96% in Q3 2026, selling an estimated $6.51M and leaving 1,945 shares worth $254K. The position accounts for 0.02% of the portfolio, ranked #280.

Counterpoint Mutual Funds first reported a position in PODD in Q3 2023 and has held it in 5 quarters since. The position peaked at $6.92M in Q2 2026. 129 funds tracked by Wall St. Rank hold PODD as of Q3 2026.

  • Counterpoint Mutual Funds held 1,945 shares of Insulet worth $254K as of Q3 2026.
  • Counterpoint Mutual Funds sold 43,514 Insulet shares in Q3 2026, an estimated $6.51M.
  • Insulet made up 0.02% of Counterpoint Mutual Funds's portfolio in Q3 2026, its #280 holding.
  • Counterpoint Mutual Funds first reported a position in Insulet in Q3 2023 and has held it in 5 quarters since.
  • Counterpoint Mutual Funds's Insulet position peaked at $6.92M in Q2 2026.
  • 129 funds tracked by Wall St. Rank held Insulet as of Q3 2026.

Based on Counterpoint Mutual Funds's 13F filing for Q3 2026, filed 16 Oct 2026.